DEEP EXPERIENCE IN AMYLOID RESEARCH, THERAPEUTIC DEVELOPMENT & COMMERCIALIZATION
A COMPANY BRINGING NEW POSSIBILITIES
Attralus aims to transform the lives of patients with systemic amyloidosis with therapeutics that remove toxic amyloid.
Our team of leading amyloidosis scientists and experts has researched and developed systemic amyloidosis therapeutics for more than 25 years.
Board of Directors
Knowledgeable business leaders and investors with demonstrated experience in building and scaling biotechnology companies.
Scientific Advisory Board
Attralus has assembled a world-class team of clinical and scientific advisors that includes recognized experts in amyloids, drug discovery, and clinical development.